NH AG targets generic drug makers for additional FDA oversight

The Attorneys General are urging the FDA to adopt standards requiring manufacturers and marketers of generic prescription painkillers to develop tamper- and abuse-resistant versions of their products.
CLICK TO VIEW THE SOURCE MATERIAL